Trials / Unknown
UnknownNCT03221504
7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children
7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 221 (estimated)
- Sponsor
- Medical University of Warsaw · Academic / Other
- Sex
- All
- Age
- 3 Months – 7 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aim to assess the effectiveness of a 7-day compared with a 10-day course of antibiotic treatment for febrile urinary tract infections (UTIs) in children. It is formulated a hypothesis that a 7-day course of antibiotic therapy is equally effective as a 10-day course of therapy and would entail a lower risk of adverse events and better compliance.
Detailed description
In previously published European and global guidelines, there has been no consensus among experts regarding the duration of therapy for a febrile UTI. Depending on the recommendation, the duration of treatment should be between 7-14 days. 221 patients aged 3 months to 7 years with febrile UTIs (defined as a combination of fever and leukocyturia in urine sediment) will be randomly assigned to receive a 7-day treatment arm (7 days of cefuroxime/cefuroxime axetil followed by 3 days of blinded placebo) or a 10-day treatment arm (7 days of cefuroxime/cefuroxime axetil followed by 3 days of blinded cefuroxime axetil). The primary outcome measure will be frequencies of recurrence and reinfection of UTI during the 6 months after the intervention. The secondary outcome measures will be antibiotic-associated diarrhea and compliance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Longer therapy duration | Patients will receive cefuroxime axetil orally. Treatment will involve the supply of cefuroxime axetil 30 mg/kg/d in two divided doses (in blinded bottles). |
| OTHER | Shorter therapy duration | Patients will receive placebo orally (in blinded bottles). The volume of the placebo will be like cefuroxime syrup. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-07-31
- Completion
- 2020-01-31
- First posted
- 2017-07-18
- Last updated
- 2018-03-20
Locations
2 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT03221504. Inclusion in this directory is not an endorsement.